Expression of Hsp90α in blood of patients with lung cancer
Ying Sun,Lin Li,Zicong He,Lin He,Shu Wang,Xiaojing Ju,Yu Li,Bin Yuan,Jianlin Xu,Changbei Shi
DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.11.016
2017-01-01
Journal of Modern Oncology
Abstract:Objective:To study the expression of heat shock protein Hsp90α in serum blood in patients with lung cancer.Methods:Statistical analysis of Hsp90α measurements in 94 patients with lung cancer and 20 cases of normal subjects,carried out comparative analysis with the consistency of serum CEA,NSE and CY211.Results:The positive rate of Hsp90α,CEA,NSE and CY211 in 94 patients with lung cancer were 42.6%,29.8%,21.3% and 38.3%.The positive rate of combined diagnosis in CEA,NSE and CY211 was 46.8%.The positive rate of combined diagnosis in Hsp90α,CEA,NSE and CY211 was 68.1%.The serum level in Hsp90α,CEA,NSE and CY211 were (110±116) ng/ml(14~551 ng/ml,median 64 ng/ml),(19±23) ng/ml(1.3~81 ng/ml,median 13 ng/ml),(17±30) ng/ml(1.6~159 ng/ml,median 6.9 ng/ml)and (12±19) ng/ml(1.1~102 ng/ml,median 4.2 ng/ml).Consistency was compared by Kappa in Hsp90α and CEA,NSE,and CY211,Kappa values were 0.5,0.58 and 0.6.According to the 0.75 standards,consistency was not satisfactory.Conclusion:The expression of heat shock protein Hsp90α is higher in the serum of patients with lung cancer.The positive rate is higher than that of CEA,NSE and CY211,and no clear correlation.Combined diagnosis can further improve the sensitivity,which is worth in further study.